These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 34248971)

  • 1. Highly Sensitized Patients Are Well Served by Receiving a Compatible Organ Offer Based on Acceptable Mismatches.
    Heidt S; Haasnoot GW; van der Linden-van Oevelen MJH; Claas FHJ
    Front Immunol; 2021; 12():687254. PubMed ID: 34248971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kidney allocation based on proven acceptable antigens results in superior graft survival in highly sensitized patients.
    Heidt S; Haasnoot GW; van Rood JJ; Witvliet MD; Claas FHJ
    Kidney Int; 2018 Feb; 93(2):491-500. PubMed ID: 28947279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allocation to highly sensitized patients based on acceptable mismatches results in low rejection rates comparable to nonsensitized patients.
    Heidt S; Haasnoot GW; Witvliet MD; van der Linden-van Oevelen MJH; Kamburova EG; Wisse BW; Joosten I; Allebes WA; van der Meer A; Hilbrands LB; Baas MC; Spierings E; Hack CE; van Reekum FE; van Zuilen AD; Verhaar MC; Bots ML; Drop ACAD; Plaisier L; Seelen MAJ; Sanders JS; Hepkema BG; Lambeck AJA; Bungener LB; Roozendaal C; Tilanus MGJ; Voorter CE; Wieten L; van Duijnhoven EM; Gelens MACJ; Christiaans MHL; van Ittersum FJ; Nurmohamed SA; Lardy NM; Swelsen W; van der Pant KAMI; van der Weerd NC; Ten Berge IJM; Bemelman FJ; Hoitsma A; van der Boog PJM; de Fijter JW; Betjes MGH; Otten HG; Roelen DL; Claas FHJ
    Am J Transplant; 2019 Oct; 19(10):2926-2933. PubMed ID: 31155833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kidney paired donation in the presence of donor-specific antibodies.
    Blumberg JM; Gritsch HA; Reed EF; Cecka JM; Lipshutz GS; Danovitch GM; McGuire S; Gjertson DW; Veale JL
    Kidney Int; 2013 Nov; 84(5):1009-16. PubMed ID: 23715120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 25th anniversary of the Eurotransplant Acceptable Mismatch program for highly sensitized patients.
    Heidt S; Witvliet MD; Haasnoot GW; Claas FH
    Transpl Immunol; 2015 Oct; 33(2):51-7. PubMed ID: 26325207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Europe wide acceptable mismatch program will enable transplantation of long waiting highly sensitised patients with a compatible donor.
    Mumford L; Fuggle SV; Martorell J; Slavcev A; Iniotaki A; Haasnoot GW; Heidt S; Claas FHJ
    Transpl Immunol; 2021 Feb; 64():101354. PubMed ID: 33276060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical relevance of pretransplant donor-directed antibodies detected by single antigen beads in highly sensitized renal transplant patients.
    van den Berg-Loonen EM; Billen EV; Voorter CE; van Heurn LW; Claas FH; van Hooff JP; Christiaans MH
    Transplantation; 2008 Apr; 85(8):1086-90. PubMed ID: 18431226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kidney Transplant With Low Levels of DSA or Low Positive B-Flow Crossmatch: An Underappreciated Option for Highly Sensitized Transplant Candidates.
    Schinstock CA; Gandhi M; Cheungpasitporn W; Mitema D; Prieto M; Dean P; Cornell L; Cosio F; Stegall M
    Transplantation; 2017 Oct; 101(10):2429-2439. PubMed ID: 28009780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allocating Deceased Donor Kidneys to Candidates with High Panel-Reactive Antibodies.
    Gebel HM; Kasiske BL; Gustafson SK; Pyke J; Shteyn E; Israni AK; Bray RA; Snyder JJ; Friedewald JJ; Segev DL
    Clin J Am Soc Nephrol; 2016 Mar; 11(3):505-11. PubMed ID: 26839235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How the definition of acceptable antigens and epitope analysis can facilitate transplantation of highly sensitized patients with excellent long-term graft survival.
    Heidt S; Haasnoot GW; Claas FHJ
    Curr Opin Organ Transplant; 2018 Aug; 23(4):493-499. PubMed ID: 29846197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transplantation of highly sensitized patients via the acceptable mismatch program or desensitization? We need both.
    Doxiadis II; Claas FH
    Curr Opin Organ Transplant; 2009 Aug; 14(4):410-3. PubMed ID: 19417658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Virtual Crossmatch: An Essential Tool for Transplanting Sensitized Patients.
    Jackson AM
    Clin Transpl; 2014; ():131-6. PubMed ID: 26281137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors Predicting Risk for Antibody-mediated Rejection and Graft Loss in Highly Human Leukocyte Antigen Sensitized Patients Transplanted After Desensitization.
    Vo AA; Sinha A; Haas M; Choi J; Mirocha J; Kahwaji J; Peng A; Villicana R; Jordan SC
    Transplantation; 2015 Jul; 99(7):1423-30. PubMed ID: 25606792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of Panel Reactive Antibodies in Renal Transplant Recipients Detected by Luminex: A Single-Center Experience.
    İnal A; Özçelik Ü; Ogan Uyanık E; Külah E; Demirağ A
    Exp Clin Transplant; 2016 Aug; 14(4):401-4. PubMed ID: 26517205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-HLA Antibody: The Role of Epitopes in Organ Transplantation.
    Argani H
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):38-42. PubMed ID: 30777521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly Sensitized Patients: Miami Transplant Institute Experience.
    Mattiazzi AD; Centeno A; Amador A; Fernandez-Bango C; Scowby CD; O'Rourke M; Hill-Matthie T; Patel R; Barrios F; Ruiz P; Chen L; Saghesima J; Ciancio G; Burke GW; Goldstein M; Chandar J; Contreras G; Roth D; Kupin W; Guerra G; Vianna R
    Clin Transpl; 2014; ():171-8. PubMed ID: 26281142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kidney transplant in highly sensitized patients after desensitization with plasmapheresis and low-dose intravenous immunoglobulin.
    Yuan XP; Wang CX; Gao W; Fu Q; He XS
    Exp Clin Transplant; 2010 Jun; 8(2):130-5. PubMed ID: 20565369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Center-defined unacceptable HLA antigens facilitate transplants for sensitized patients in a multi-center kidney exchange program.
    Baxter-Lowe LA; Cecka M; Kamoun M; Sinacore J; Melcher ML
    Am J Transplant; 2014 Jul; 14(7):1592-8. PubMed ID: 24934640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term Outcomes of Kidney Transplantation in Patients With High Levels of Preformed DSA: The Necker High-Risk Transplant Program.
    Amrouche L; Aubert O; Suberbielle C; Rabant M; Van Huyen JD; Martinez F; Sberro-Soussan R; Scemla A; Tinel C; Snanoudj R; Zuber J; Cavalcanti R; Timsit MO; Lamhaut L; Anglicheau D; Loupy A; Legendre C
    Transplantation; 2017 Oct; 101(10):2440-2448. PubMed ID: 28114171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.